Clinical Significance of T-SPOT.TB Test in Patients With Uveitis in South Korea
Song JS, Song SH, Kim MS
American journal of ophthalmology · 2025-11
Abstract
Purpose To investigate the clinical significance of T-SPOT.TB results in patients with uveitis in South Korea, an intermediate tuberculosis (TB) burden country, and to compare clinical characteristics and treatment patterns by T-SPOT.TB results. Design Retrospective clinical cohort study. Methods This study included 382 patients diagnosed with uveitis who underwent both T-SPOT.TB test with interpretable results and chest imaging at a tertiary referral center between 2013 and 2022. Clinical data, including the anatomical location of uveitis and treatment regimens, were compared between T-SPOT.TB-positive and negative groups. Additional analyses compared pulmonology referrals, antitubercular therapy administration, and chest imaging and microbiologic findings. Results Among 382 patients, 125 (32.7%) were T-SPOT.TB-positive. The T-SPOT.TB-positive group had a higher mean age (55.9 vs 42.5 years, P Conclusions In this real-world cohort from a TB intermediate-burden country, T-SPOT.TB positivity was not associated with clinical features or treatment burden of uveitis. The findings suggest that T-SPOT.TB positivity in uveitis patients may reflect background latent infection rather than active ocular involvement.
MeSH terms
- Humans
- Mycobacterium tuberculosis
- Tuberculosis, Ocular
- Uveitis
- Antitubercular Agents
- Retrospective Studies
- Adult
- Aged
- Middle Aged
- Female
- Male
- Young Adult
- Republic of Korea
- Interferon-gamma Release Tests
- Clinical Relevance